|
LOC646471 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.638100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.564400E-03 |
| Normal-vs-Stage2 |
9.517800E-02 |
| Normal-vs-Stage3 |
3.768000E-04 |
| Normal-vs-Stage4 |
5.110100E-02 |
| Stage1-vs-Stage2 |
4.059200E-01 |
| Stage1-vs-Stage3 |
1.729050E-01 |
| Stage1-vs-Stage4 |
7.584400E-01 |
| Stage2-vs-Stage3 |
1.046370E-01 |
| Stage2-vs-Stage4 |
7.082400E-01 |
| Stage3-vs-Stage4 |
2.574200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.184260E-03 |
| Normal-vs-AfricanAmerican |
1.248650E-01 |
| Normal-vs-Asian |
1.884370E-01 |
| Caucasian-vs-AfricanAmerican |
6.992200E-01 |
| Caucasian-vs-Asian |
1.613560E-01 |
| AfricanAmerican-vs-Asian |
5.631200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.075900E-02 |
| Normal-vs-Female |
2.280700E-03 |
| Male-vs-Female |
2.444600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.176600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.599200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.137800E-02 |
| Normal-vs-Age(81-100Yrs) |
8.443300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.751400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.996200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.921180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.799000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.954500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.537600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.19350000052465E-07 |
| Classical-VS-Follicular |
7.968800E-01 |
| Classical-VS-Other |
8.625800E-01 |
| Classical-VS-Normal |
6.295800E-03 |
| Tall-VS-Follicular |
7.61200000000128E-05 |
| Tall-VS-Other |
1.718300E-02 |
| Tall-VS-Normal |
3.401599999453E-07 |
| Follicular-VS-Other |
9.235800E-01 |
| Follicular-VS-Normal |
1.751570E-02 |
| Other-VS-Normal |
2.558400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.143600E-03 |
| Normal-vs-N1 |
3.876200E-01 |
| N0-vs-N1 |
1.771770E-01 |
|
|
